학술논문

Phase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 1 September 2023, 29(17):3301-3312)
Subject
Language
English
ISSN
15573265
10780432